For instance, aberrant expression of proteins or peptides with specific post-translational modifications detected in cancer (e.g., phosphorylation, acetylation, and citrullination) have been shown to trigger CD4 and CD8 T-cell responses26–30. The gene discussed is CD8A; the disease is cancer.